The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.
 
Charles N. Landen
Leadership - Tina's Wish
Consulting or Advisory Role - Genentech; Mercy BioAnalytics
 
Ronald J. Buckanovich
Stock and Other Ownership Interests - Tradewind BioScience
Research Funding - Novartis (Inst)
 
Michael Sill
No Relationships to Disclose
 
Robert S. Mannel
Stock and Other Ownership Interests - Danaher; Edwards Lifesciences; Stryker
 
Joan L. Walker
Research Funding - Genentech; Pieces Tech (Inst); us biotest
 
Paul Disilvestro
Consulting or Advisory Role - Agenus; AstraZeneca
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech (Inst); Janssen Oncology (Inst); Tesaro (Inst)
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Deciphera (Inst); EMD Serono (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
David Gardner Mutch
Consulting or Advisory Role - lilly
 
Marcia Hernandez
No Relationships to Disclose
 
Lainie P. Martin
Consulting or Advisory Role - Elucida Oncology; GlaxoSmithKline; Sutro Biopharma
Research Funding - Agenus (Inst); AstraZeneca (Inst); Immunogen (Inst); Sutro bioPharma (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Erin Bishop
No Relationships to Disclose
 
Sarah Gill
No Relationships to Disclose
 
Mary E Gordinier
No Relationships to Disclose
 
Robert Allen Burger
Employment - Genentech/Roche; Mersana
Stock and Other Ownership Interests - Genentech/Roche; Mersana
Consulting or Advisory Role - Myriad Genetics
 
Carol Aghajanian
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; Eisai; Eisai; Mersana; Repare Therapeutics; Roche; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; GlaxoSmithKline; Regeneron
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Regeneron (Inst); Surface Oncology (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst); Zentalis (Inst)
(OPTIONAL) Uncompensated Relationships - Merck
 
Kathleen N. Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Great Debates and Updates; Physicans' Education Resource; Prime Oncology; Research To Practice
Consulting or Advisory Role - Alkermes (Inst); Aravive; AstraZeneca; Blueprint Medicines (Inst); Eisai; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); I-Mab (Inst); Immunogen; InxMed (Inst); Merck; Mereo BioPharma; Mereo BioPharma (Inst); Mersana (Inst); Myriad Genetics; Novartis; Onconova Therapeutics; OncXerna Therapeutics; TESARO (Inst); Vavotar Life Sciences; VBL Therapeutics
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); Amgen (Inst); artios (Inst); AstraZeneca (Inst); Bayer (Inst); Bolt Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); cyteir (Inst); Daiichi Sankyo/Lilly (Inst); Forty Seven (Inst); Genentech (Inst); Immunocore (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - GOG Partners (Inst)
 
Michael A. Bookman
Employment - The Permanente Medical Group
Consulting or Advisory Role - Abbvie; Aravive; AstraZeneca; Genentech/Roche; Immunogen; Merck Sharp & Dohme; Seagen